IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q2 2017 Holdings

Filed 2017-08-10 | 6 holdings | $92.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$49.0K2,956,45652.7%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$19.0K2,579,49020.4%
Ocular Therapeutix Inc(OCUL)COM67576A100$14.9K1,605,20716.0%
Transenterix IncCOM NEW89366M201$5.4K7,546,6925.8%
Catabasis Pharmaceuticals inCOM14875P107$4.0K2,857,6674.3%
Lombard MED IncCOMG55598109$7011,275,7790.8%